Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Utilization of Prophylactic Autologous Blood Patch Pleurodesis in the Treatment of Primary Spontaneous Pneumothorax

NCT06088901 is registered in ClinicalTrials.gov with Rush University Medical Center as lead sponsor.

NCT NCT06088901
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06088901 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Utilization of Prophylactic Autologous Blood Patch Pleurodesis in the Treatment of Primary Spontaneous Pneumothorax
Lead sponsor
Rush University Medical Center
Phase
Not applicable
Overall status
Withdrawn
Start date
July 31, 2024
Completion date
July 31, 2027
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary spontaneous pneumothorax